Form 4: Emergent BioSolutions SVP William Hartzel Reports Stock Disposal for Tax Obligations
SEC Form 4 Filing
William Hartzel, SVP of Bioservices at Emergent BioSolutions, disposed of 561 shares of common stock on April 7, 2025, to cover tax obligations related to vesting and settlement of restricted stock units.
Summary
- On April 7, 2025, William Hartzel, SVP of Bioservices at Emergent BioSolutions, disposed of 561 shares of common stock.
- The transaction was executed to cover tax obligations associated with the vesting and settlement of restricted stock units.
- The shares were disposed of at a price of $4.44 per share.
- Following the transaction, Hartzel directly owns 109,122 shares of Emergent BioSolutions common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors.
Key Dates
| Date | Description |
|---|---|
| 04/07/2025 | Date of stock disposal transaction. |
| 04/09/2025 | Date of signature for the Form 4 filing. |
Keywords
Emergent BioSolutions, Hartzel, Form 4, Stock Disposal, Insider Trading, Beneficial Ownership, Tax Obligations, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.